11
Bik-Simonis, A.M.C., Eekhoff, E.M.W., Diamant, M., Boomsma, D.I., Heine, R.J., Dekker, J.M., Willemsen, G., van Leeuwen, M., de Geus, E.J.C.
Veröffentlicht in: Bik-Simonis , A M C , Eekhoff , E M W , Diamant , M , Boomsma , D I , Heine , R J , Dekker , J M , Willemsen , G , van Leeuwen , M & de Geus , E J C 2008 , ' The heritability of HbA1c and fasting blood glucose in different measurement settings. ' , Twin Research and Human Genetics , vol. 11 , no. 6 , pp. 597-602 . https://doi.org/10.1375/twin.11.6.597;
2008
Veröffentlicht in: Bik-Simonis , A M C , Eekhoff , E M W , Diamant , M , Boomsma , D I , Heine , R J , Dekker , J M , Willemsen , G , van Leeuwen , M & de Geus , E J C 2008 , ' The heritability of HbA1c and fasting blood glucose in different measurement settings. ' , Twin Research and Human Genetics , vol. 11 , no. 6 , pp. 597-602 . https://doi.org/10.1375/twin.11.6.597;
2008
12
Selvarajah, A., Tavenier, A. H., Bor, W. L., Houben, V., Rasoul, S., Kaplan, E., Teeuwen, K., Hofma, S. H., Lipsic, E., Amoroso, G., van Leeuwen, M. A. H., Berg, J. M. ten, van ‘t Hof, A. W. J., Hermanides, R. S.
Veröffentlicht in: BMC Cardiovascular Disorders ; volume 21, issue 1 ; ISSN 1471-2261;
2021
Veröffentlicht in: BMC Cardiovascular Disorders ; volume 21, issue 1 ; ISSN 1471-2261;
2021
13
14
Selvarajah, A., Tavenier, A. H., Bor, W. L., Houben, J.E.M., Rasoul, S., Kaplan, E., Teeuwen, K., Hofma, S. H., Lipsic, E., Amoroso, G., van Leeuwen, M. A. H., ten Berg, J. M., van 't Hof, A. W. J., Hermanides, R. S.
Veröffentlicht in: Selvarajah , A , Tavenier , A H , Bor , W L , Houben , J E M , Rasoul , S , Kaplan , E , Teeuwen , K , Hofma , S H , Lipsic , E , Amoroso , G , van Leeuwen , M A H , ten Berg , J M , van 't Hof , A W J & Hermanides , R S 2021 , ' Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention : rationale of the Dutch Cangrelor Registry ' , BMC Cardiovascular Disorders , vol. 21 , no. 1 , 292 . https://doi.org/10.1186/s12872-021-02093-4;
2021
Veröffentlicht in: Selvarajah , A , Tavenier , A H , Bor , W L , Houben , J E M , Rasoul , S , Kaplan , E , Teeuwen , K , Hofma , S H , Lipsic , E , Amoroso , G , van Leeuwen , M A H , ten Berg , J M , van 't Hof , A W J & Hermanides , R S 2021 , ' Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention : rationale of the Dutch Cangrelor Registry ' , BMC Cardiovascular Disorders , vol. 21 , no. 1 , 292 . https://doi.org/10.1186/s12872-021-02093-4;
2021
15